Skip to content

Frosh v. Association for Accessible Medicines

Petition for certiorari denied on February 19, 2019

Docket No. Op. Below Argument Opinion Vote Author Term
18-546 4th Cir. N/A N/A N/A N/A OT 2018

Issue: Whether the commerce clause prohibits a state from protecting consumer access to essential off-patent and generic prescription drugs by requiring manufacturers to refrain from unconscionably raising the price of those drugs sold in the state.

SCOTUSblog Coverage

DateProceedings and Orders (key to color coding)
10/19/2018Petition for a writ of certiorari filed. (Response due November 26, 2018)
11/01/2018Blanket Consent filed by Petitioners, Brian Frosh, et al.
11/05/2018Waiver of right of respondent Association for Accessible Medicines to respond filed.
11/05/2018Blanket Consent filed by Respondents, Association for Accessible Medicines.
11/07/2018DISTRIBUTED for Conference of 11/30/2018.
11/13/2018Response Requested. (Due December 13, 2018)
11/15/2018Motion to extend the time to file a response from December 13, 2018 to January 14, 2019, submitted to The Clerk.
11/16/2018Motion to extend the time to file a response is granted and the time is extended to and including January 14, 2019.
11/21/2018Brief amici curiae of Gerard F. Anderson; Joshua M. Sharfstein filed.
12/13/2018Brief amici curiae of Legal Scholars filed.
12/13/2018Brief amici curiae of National Health Law Program, et al. filed.
01/14/2019Brief of respondent Association for Accessible Medicines in opposition filed.
01/25/2019Reply of petitioners Brian Frosh, et al. filed.
01/30/2019DISTRIBUTED for Conference of 2/15/2019.
02/19/2019Petition DENIED.